A new partnership between the province and a US based healthcare company will enable Cancer patients in Nova Scotia to be some of the first to access new technology and innovative programs developed in the fight against the disease, says the Tory government.Nova Scotia Health and Varian, a U.S.-based Siemens Healthineers company that provides cancer care technologies, have entered a 10-year multi-disciplinary oncology partnership that includes utilizing artificial intelligence in digital imaging and will modernize the way cancer care is delivered in the province and around the world.
"Fixing healthcare in our province means keeping pace with the latest advancements in technology, equipment and training," said Premier Tim Houston in a news release. "This partnership will foster a future where cancer care is a journey filled with hope, support and unparalleled advancements.
"The partnership will provide Nova Scotia with new, state-of-the-art equipment and software to expand the ongoing oncology transformation project across the province. According to the province, the benefits will include the expansion of the provincial cancer screening and cancer survivorship programs, earlier detection of cancers with improved diagnostics, treatments that are less invasive and more personalized, and improved outcomes for patients.
Nova Scotia Health will invest up to $224 million over the next 10 years in the project. That includes $175 million to purchase hardware, software and digital solutions and services, and $49 million for renovations to accommodate new equipment and create new positions to support the project.Varian has also committed up to $50 million over the same period to open a new office in Halifax that will create at least 60 jobs.
The Halifax office will work with Nova Scotia Health to develop a digital imaging concept around artificial intelligence.
Image credits: premier.novascotia.ca